Bio-Thera Solutions Ltd (688177) — Capital Reinvestment Ratio

Latest as of December 2021: 0.07x

Bio-Thera Solutions Ltd (688177) has a Capital Reinvestment Ratio of 0.07x as of December 2021, meaning it reinvests 0% of its operating cash flow (CN¥368.97 Million) in capital expenditures (CN¥26.25 Million). Check 688177 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

CN¥368.97 Million

CNY

Capital Expenditures

CN¥26.25 Million

CNY

Data as of

Dec 2021

Most recent filing

Bio-Thera Solutions Ltd Capital Reinvestment Ratio (2021–2021)

This chart tracks Bio-Thera Solutions Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Bio-Thera Solutions Ltd.

Annual Capital Reinvestment Ratio for Bio-Thera Solutions Ltd (2021–2021)

Year-by-year Capital Reinvestment Ratio for Bio-Thera Solutions Ltd from 2021 to 2021. See free cash flow generation of Bio-Thera Solutions Ltd to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CNY)	Capital Expenditures	YoY Change
2021	0.33x	CN¥236.27 Million	CN¥77.89 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow